Monitor for any future conversion to SC 13D if Darwin Global's intent changes, but as a passive 13G filing, no near-term activist catalyst is expected. The stake is notable for its size (5.9%) and the identity of the filer (Darwin Global Management, a hedge fund manager).
Price Chart
Executive Summary
Darwin Global Management, Ltd. and related entities filed a new Schedule 13G disclosing a 5.9% passive stake in Genmab A/S as of September 28, 2026. The filing indicates no intent to influence control, and the stake is held through ordinary shares and ADSs. This is a new filer on this issuer, distinct from the prior Orbis Investment Management filings.
Key Financial Metrics
Key Facts
- Darwin Global Management, Ltd. and related entities (Dr. Abhishek Trehan, Darwin Global Master Fund, Ltd.) filed a new Schedule 13G on October 5, 2026.
- Aggregate beneficial ownership: 3,668,310 ordinary shares (including ADSs), representing 5.9% of shares outstanding.
- The stake is held via 1,825,006 ordinary shares and 18,433,047 ADSs (each ADS = 1/10 ordinary share).
- Darwin Global Master Fund, Ltd. directly holds 3,569,746 ordinary shares (including ADSs), representing 5.7%.
- The filing is under Rule 13d-1(c) and certifies passive intent — no control influence.
- This is a new filer; prior SC 13G/A filings for Genmab were by Orbis Investment Management Ltd.
Financial Impact
5.9% passive stake in Genmab A/S; no transaction value disclosed.
Risk Factors
- Potential future conversion to activist filing (SC 13D) if investment thesis changes.
- No explicit disclosure of cost basis or entry price — exit risk unknown.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000902664-26-004067 |
| Document: 0000902664-26-004067-index-headers.html | 0000902664-26-004067 |
| Document: 0000902664-26-004067-index.html | 0000902664-26-004067 |
| Document: 0000902664-26-004067.txt | 0000902664-26-004067 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | 6-K | $42.64 | awaiting T+1 | — | $43.79 (+2.70%) |
Oct 13, 2026 13d ago | 6-K | $36.57 $36.89 | ▲ +0.88% | ▲ +1.96% | $43.79 (+19.74%) |
Oct 7, 2026 18d ago | 6-K | $36.65 $36.05 | ▼ −1.64% | ▼ −1.21% | $43.79 (+19.48%) |
Oct 5, 2026 20d ago | SC 13G | $37.80 $36.65 | ▼ −3.04% | ▼ −2.80% | $43.79 (+15.85%) |
Oct 5, 2026 20d ago | 6-K | $38.48 $37.80 | ▼ −1.77% | ▼ −2.32% | $43.79 (+13.80%) |
Oct 2, 2026 23d ago | 6-K | $34.75 $38.48 | ▲ +10.73% | ▲ +10.06% | $43.79 (+26.01%) |
Sep 29, 2026 26d ago | 6-K | $35.57 $35.68 | ▲ +0.30% | ▲ +0.50% | $43.79 (+23.11%) |
Sep 24, 2026 4w ago | 6-K | $34.83 $35.32 | ▲ +1.41% | ▲ +0.86% | $43.79 (+25.72%) |
Sep 8, 2026 6w ago | 6-K | $33.53 $33.04 | ▼ −1.46% | ▼ −1.00% | $43.79 (+30.60%) |
Aug 12, 2026 10w ago | 6-K | $31.42 $31.34 | ▼ −0.25% | ▼ −0.95% | $43.79 (+39.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers